CGM market to grow by USD 2.59B from 2022-27

The continuous glucose monitoring market is estimated to grow by USD 2.59 billion from 2022 to 2027 at a CAGR of 6.37% according to Technavio.

The rise in the diabetic population drives the CGM market growth
The surge in the number of diabetes cases is attributed to factors such as obesity, smoking, a sedentary lifestyle, and urbanization. Moreover, the elderly population is particularly vulnerable to diabetes. The increasing prevalence of diabetes is a key driver for market growth.

A lower diagnosis and treatment rate is a major challenge hindering the CGM market.

Market overview
The Continuous Glucose Monitoring (CGM) market is witnessing significant growth, fueled by advancements in noninvasive glucose monitoring devices approved by regulatory bodies like the United States Government Food and Drug Administration. CGM systems offer invaluable support to diabetes patients by providing real-time glucose level data, particularly critical for type-1 diabetes patients. Hospitals and ICUs increasingly integrate CGM technology to enhance patient care, especially for diabetes patients requiring intensive monitoring. Both type-1 and type-2 diabetes patients benefit from CGM devices, which offer continuous insights into glucose levels, aiding in better management and reducing risks. With endorsements from entities like the Centers for Disease Control and Prevention, the CGM market continues to expand, catering to the evolving needs of diabetes patients. Technavio